Cancer Research Services For Medical Specialties
-
based in INDIA
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from their data. We are a team of data analysis experts, bioinformatics tool developers, and life scientists determined to simplify, enhance, and innovate the ...
-
based in INDIA
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from their data. We are a team of data analysis experts, bioinformatics tool developers, and life scientists determined to simplify, enhance, and innovate the ...
-
Manufactured by Ozgene Pty Ltd.based in AUSTRALIA
Humanized mice broadly refers to mice expressing human genes via transgenesis to gain relevant insights in the in vivo context for the understanding of human-specific physiology and pathology. Whilst many basic biological insights have been obtained from mouse studies, there are limitations to mouse models when investigating human biology. There are components of mouse biology systems that are ...
-
based in USA
Health research is our largest single field of study, encompassing research that ranges from studies of the human genome and the development of new drug compounds to national surveys of health behaviors and the implementation of global health programs. Building on our extensive research expertise and working with staff members at RTI Health Solutions, our commercial subsidiary, we form ...
-
based in USA
Bespoke AI models created for you: Whether you are looking to accelerate your preclinical analysis or scale your pathology services, you can now enhance your image analysis workflow with Aiforia. With our Custom AI Services Aiforia scientists build AI models for your specific needs. With AI you can automate manual image analysis tasks to save time and costs, standardize analysis across your whole ...
-
based in USA
Cytogenetics is the study of normal and abnormal chromosomes in relation to disease. Sometimes called chromosome analysis or karyotyping, cytogenetic tests are used to gain diagnostic and prognostic insights regarding solid tumor cancers and hematologic malignancies, which can be the result of chromosome rearrangements or altered chromosome number (ploidy). Our cytogenetic tests include a ...
-
Manufactured by Grail, Inc.based in USA
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. SUMMIT aims to further evaluate GRAIL’s blood ...
-
based in USA
It took nearly a century of research for doctors to learn what causes this cancer, who is most at risk for contracting it, what symptoms indicate its presence and what tools are most effective at diagnosing it. These strides significantly impacted how medical professionals treat asbestos cancer, but the investigation is hardly finished. Current efforts on developing more effective treatments and ...
-
Manufactured by Grail, Inc.based in USA
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to detect and localize multiple types of cancer through a single blood draw, with a very ...
-
Manufactured by Mesothelioma + Asbestos Awareness Centerbased in USA
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this deadly disease. Many of the commonly used methods of treating cancer today were once experimental, and the hope is that new, even more effective ...
-
by Genmab A/Sbased in DENMARK
Using our antibody expertise to transform how cancer is treated; As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation cancer treatments. Our research and innovation teams ...
-
Manufactured by Data Driven Diagnostic Sciences (D3Sciences)based in USA
Detecting, Diagnosing and Treating Cancer: To detect, diagnose, and treat internal cancer requires a team of healthcare providers led generally by three specialist physicians: oncologists, radiologists, and pathologists. Upon examining a patient, and assessing the indicators for the presence of the disease, the oncologist consults with the radiologist and the decision is made for the radiologist ...
-
based in CANADA
Find It focuses on gene mutations that can be addressed by current FDA-approved therapies. Find It is more than an assay: it’s a complete solution. Canexia Health partners leverage our expert end-to-end support and proprietary technology as well as a focused panel that identifies therapeutic targets for patients, acquired drug resistance mutations, and mutations with prognostic and ...
-
based in CANADA
While tissue samples are the standard for cancer molecular profiling, tissue can often be challenging to obtain. Surgical biopsy may be risky or impossible, the biopsy procedure may have resulted in insufficient or exhausted tissue, or the sample acquired resulted in poor quality DNA. Whatever the reason, plasma assays can provide a less invasive alternative or complement to tissue assays. Plasma ...
-
Manufactured by Grail, Inc.based in USA
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
-
Manufactured by Veracytebased in FRANCE
Leverage the widely used Nanostring platform to study gene expression in the tumor microenvironment, revealing biomarker signatures, mechanism of action, disease biology, and more. The most popular Nanostring service we offer is the nCounter® PanCancer IO 360™ Panel. This panel is designed to deliver immuno-oncology insights for translational research and assesses the expression of 770 ...
-
based in USA
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
-
based in UNITED KINGDOM
I.S.S. is a proud UK based manufacturer that has established over many decades an expertise in the production and supply of laboratory ...
-
Manufactured by BioMark Diagnostics Inc.based in CANADA
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
-
Manufactured by Alfa Chemistrybased in USA
Ifosfamide has been effectively employed in the treatment of multiple cancers, including testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, epithelial ovarian cancer, cervical carcinoma and germ cell carcinoma of the ovary[1]. Among all these cancers, the Food and Drug Administration (FDA) has approved ifosfamide ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you